Bioventix (BVXP)

 

Latest News

Result of AGM

Bioventix plc (?Bioventix? or the ?Company?) Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting (?AGM?), all resolutions put to shareholders were duly passed. Prior to the AGM, Resolution 5 was withdrawn. For further information please contact: Bioventix plc Peter Harrison Chief Executive Officer Tel: 01252 728 001 finnCap L...

Director Deals - Bioventix Plc (BVXP)

Peter Harrison, Chief Executive Officer, sold 80,000 shares in the company on the 19th October 2017 at a price of 2425.00p. ...

Director Deals - Bioventix Plc (BVXP)

Ian Nicholson, Chairman, sold 5,000 shares in the company on the 19th October 2017 at a price of 2400.75p. The Director no...

Director/PDMR Shareholding

Bioventix plc (?Bioventix? or the ?Company?) Director/PDMR Shareholding Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for application in clinical diagnostics, was notified on 19 October 2017 of the following transactions in its ordinary shares of 5 pence each (?Ordinary Shares?)...

All News

DateHeadlineSource
18-12-17Result of AGMRNS
20-10-17Director Deals - Bioventix Plc (BVXP)StockMarketWire
20-10-17Director Deals - Bioventix Plc (BVXP)StockMarketWire
20-10-17Director/PDMR ShareholdingRNS
20-10-17Holding(s) in CompanyRNS
16-10-17Broker Forecast - finnCap issues a broker note on Bioventix PlcStockMarketWire
16-10-17Bioventix pre-tax profits up 37%StockMarketWire
16-10-17Final ResultsRNS
20-09-17Holding(s) in CompanyRNS
04-09-17A small-cap pharma still smashing City forecastsInteractive Investor
04-09-17Bioventix ahead of forecasts StockMarketWire
04-09-17Trading Update, Notice of Results & AGMRNS
14-08-17Holding(s) in CompanyRNS
07-08-17Holding(s) in CompanyRNS
26-07-1710 of the best-quality companies on AIMInteractive Investor
10-05-17Bioventix to get royalties from Siemens troponin testStockMarketWire
10-04-17Holding(s) in CompanyRNS
03-04-17Holding(s) in CompanyRNS
30-03-17Issue of EquityRNS
27-03-17Broker Forecast - finnCap issues a broker note on Bioventix PlcStockMarketWire
27-03-17Bioventix pre-tax profits rise StockMarketWire
27-03-17Interim ResultsRNS
08-03-1710 fast-paced growth stocks for all tradersInteractive Investor
20-01-17Five shares for the watchlistMoney Observer
13-01-17Holding(s) in CompanyRNS
05-01-17Holding(s) in CompanyRNS
08-12-16Bioventix resolutions passed at AGM StockMarketWire
07-12-16Result of AGMRNS
18-11-16Director/PDMR ShareholdingRNS
14-11-16Notice of AGMRNS
17-10-16Broker Forecast - finnCap issues a broker note on Bioventix PlcStockMarketWire
17-10-16Final ResultsRNS
10-10-16Second Price Monitoring ExtnRNS
10-10-16Second Price Monitoring ExtnRNS
10-10-16Price Monitoring ExtensionRNS
31-08-1610 AIM shares with big advantageInteractive Investor
23-08-16Broker Forecast - finnCap issues a broker note on Bioventix PlcStockMarketWire
22-08-16Commodity prices weigh on FTSE StockMarketWire
22-08-16FTSE holds ground amid summer lull StockMarketWire
22-08-16Trading Update and Notice of ResultsRNS

RSS feeds

  • Editorial news feed for LSE:BVXP Editorial
  • Regulatory news feed for LSE:BVXP Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account